Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: Type 2 Diabetes

<p>Abstract</p> <p>Background</p> <p>Visceral adiposity index (VAI) has recently been developed based on waist circumference, body mass index (BMI), triglycerides (TGs), and high-density lipoprotein cholesterol (HDL-C). We examined predictive performances for incident d...

Full description

Bibliographic Details
Main Authors: Azizi Fereidoun, Hadaegh Farzad, Bozorgmanesh Mohammadreza
Format: Article
Language:English
Published: BMC 2011-05-01
Series:Lipids in Health and Disease
Online Access:http://www.lipidworld.com/content/10/1/88
_version_ 1818562437561974784
author Azizi Fereidoun
Hadaegh Farzad
Bozorgmanesh Mohammadreza
author_facet Azizi Fereidoun
Hadaegh Farzad
Bozorgmanesh Mohammadreza
author_sort Azizi Fereidoun
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Visceral adiposity index (VAI) has recently been developed based on waist circumference, body mass index (BMI), triglycerides (TGs), and high-density lipoprotein cholesterol (HDL-C). We examined predictive performances for incident diabetes of the VAI per se and as compared to the metabolic syndrome (MetS) and waist-to-height-ratio (WHtR).</p> <p>Methods</p> <p>Participants free of diabetes at baseline with at least one follow-up examination (5,964) were included for the current study. Weibull regression models were developed for interval-censored survival data. Absolute and relative integrated discriminatory improvement index (IDI) and cut-point-based and cut-point-free net reclassification improvement index (NRI) were used as measures of predictive ability for incident diabetes added by VAI, as compared to the MetS and WHtR.</p> <p>Results</p> <p>The annual incidence rate of diabetes was 0.85 per 1000 person. Mean VAI was 3.06 (95%CIs 2.99-3.13). Diabetes risk factors levels increased in stepwise fashion across VAI quintiles. Risk gradient between the highest and lowest quintile of VAI was 4.5 (95%CIs 3.0-6.9). VAI significantly improved predictive ability of the MetS. The relative IDI and cut-point free NRI for predictive ability added to MetS by VAI were 30.3% (95%CIs 18.8-41.8%) and 30.7% (95%CIs 20.8-40.7%), respectively. WHtR, outperformed VAI with cut-point-free NRI of 24.6% (95%CIs 14.1-35.2%).</p> <p>Conclusions</p> <p>In conclusion, although VAI could be a prognostic tool for incident diabetes events, gathering information on its components (WC, BMI, TGs, and HDL-C) is unlikely to improve the prediction ability beyond what could be achieved by the simply assessable and commonly available information on WHtR.</p>
first_indexed 2024-12-14T01:03:43Z
format Article
id doaj.art-14ef517589144c5292ea940ce3d6d54f
institution Directory Open Access Journal
issn 1476-511X
language English
last_indexed 2024-12-14T01:03:43Z
publishDate 2011-05-01
publisher BMC
record_format Article
series Lipids in Health and Disease
spelling doaj.art-14ef517589144c5292ea940ce3d6d54f2022-12-21T23:23:05ZengBMCLipids in Health and Disease1476-511X2011-05-011018810.1186/1476-511X-10-88Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: Type 2 DiabetesAzizi FereidounHadaegh FarzadBozorgmanesh Mohammadreza<p>Abstract</p> <p>Background</p> <p>Visceral adiposity index (VAI) has recently been developed based on waist circumference, body mass index (BMI), triglycerides (TGs), and high-density lipoprotein cholesterol (HDL-C). We examined predictive performances for incident diabetes of the VAI per se and as compared to the metabolic syndrome (MetS) and waist-to-height-ratio (WHtR).</p> <p>Methods</p> <p>Participants free of diabetes at baseline with at least one follow-up examination (5,964) were included for the current study. Weibull regression models were developed for interval-censored survival data. Absolute and relative integrated discriminatory improvement index (IDI) and cut-point-based and cut-point-free net reclassification improvement index (NRI) were used as measures of predictive ability for incident diabetes added by VAI, as compared to the MetS and WHtR.</p> <p>Results</p> <p>The annual incidence rate of diabetes was 0.85 per 1000 person. Mean VAI was 3.06 (95%CIs 2.99-3.13). Diabetes risk factors levels increased in stepwise fashion across VAI quintiles. Risk gradient between the highest and lowest quintile of VAI was 4.5 (95%CIs 3.0-6.9). VAI significantly improved predictive ability of the MetS. The relative IDI and cut-point free NRI for predictive ability added to MetS by VAI were 30.3% (95%CIs 18.8-41.8%) and 30.7% (95%CIs 20.8-40.7%), respectively. WHtR, outperformed VAI with cut-point-free NRI of 24.6% (95%CIs 14.1-35.2%).</p> <p>Conclusions</p> <p>In conclusion, although VAI could be a prognostic tool for incident diabetes events, gathering information on its components (WC, BMI, TGs, and HDL-C) is unlikely to improve the prediction ability beyond what could be achieved by the simply assessable and commonly available information on WHtR.</p>http://www.lipidworld.com/content/10/1/88
spellingShingle Azizi Fereidoun
Hadaegh Farzad
Bozorgmanesh Mohammadreza
Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: Type 2 Diabetes
Lipids in Health and Disease
title Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: Type 2 Diabetes
title_full Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: Type 2 Diabetes
title_fullStr Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: Type 2 Diabetes
title_full_unstemmed Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: Type 2 Diabetes
title_short Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: Type 2 Diabetes
title_sort predictive performance of the visceral adiposity index for a visceral adiposity related risk type 2 diabetes
url http://www.lipidworld.com/content/10/1/88
work_keys_str_mv AT azizifereidoun predictiveperformanceofthevisceraladiposityindexforavisceraladiposityrelatedrisktype2diabetes
AT hadaeghfarzad predictiveperformanceofthevisceraladiposityindexforavisceraladiposityrelatedrisktype2diabetes
AT bozorgmaneshmohammadreza predictiveperformanceofthevisceraladiposityindexforavisceraladiposityrelatedrisktype2diabetes